Brean Murray initiates coverage on NPS Pharmaceuticals (Nasdaq: NPSP) with a Buy. Price target $11.

Brean analyst says, "With the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE